American Cancer Society Statistics 2009 Slides

Cancer Statistics 2009
A Presentation From the

American Cancer Society
©2009, American Cancer Society, Inc.

2009 Estimated US Cancer Deaths*
Lung & bronchus 30% Men Women 26% Lung & bronchus
292,540 269,800
Prostate 9% 15% Breast
Colon & rectum 9% 9% Colon & rectum
Pancreas 6% 6% Pancreas
Leukemia 4% 5% Ovary
Liver & intrahepatic 4% 4% Non-Hodgkin
bile duct lymphoma
Esophagus 4% 3% Leukemia
Urinary bladder 3% 3% Uterine corpus
Non-Hodgkin 3% 2% Liver & intrahepatic
lymphoma bile duct
Kidney & renal pelvis 3% 2% Brain/ONS
All other sites 25% 25% All other sites
ONS=Other nervous system.

Source: American Cancer Society, 2009.
US Mortality, 2006
No. of % of all
Rank Cause of Death deaths deaths
1. Heart Diseases 631,636 26.0
2. Cancer 559,888 23.1
3. Cerebrovascular diseases 137,119 5.7
4. Chronic lower respiratory diseases 124,583 5.1
5. Accidents (unintentional injuries) 121,599 5.0
6. Diabetes mellitus 72,449 3.0
7. Alzheimer disease 72,432 3.0
8. Influenza & pneumonia 56,326 2.3
9. Nephritis* 45,344 1.9
10. Septicemia 34,234 1.4
*Includes nephrotic syndrome and nephrosis.

Source: US Mortality Data 2006, National Center for Health Statistics, Centers for Disease Control and Prevention,
2009.
Change in US Death Rates* from 1991 to 2006
Rate Per 100,000

400
1991
313.0
300 2006
215.1
200.2
200 180.7
100
63.3
43.6 34.8
17.8
0
Heart diseases Cerebrovascular Influenza & Cancer
diseases pneumonia
* Age-adjusted to 2000 US standard population.

Sources: US Mortality Data, National Center for Health Statistics, Centers for Disease Control and
Prevention, 2009.
Trends in the Number of Cancer Deaths Among Men and
Women, US, 1930-2006
300,000 295,000
Men
290,000
Men
285,000
250,000
280,000
Number of Cancer Deaths
Women 275,000
200,000 Women
270,000
265,000
150,000
100,000
50,000
0
1930 1940 1950 1960 1970 1980 1990 2000
Source: US Mortality Data, 1930-2006, National Center for Health Statistics, Centers for Disease
Control and Prevention, 2009.
Cancer Death Rates* by Sex, US, 1975-2005
300 Rate Per 100,000

Men
250
Both Sexes
200
Women
150
100
50
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
*Age-adjusted to the 2000 US standard population.
Source: US Mortality Data 1960-2005, National Center for Health Statistics, Centers for Disease Control and
Prevention, 2008.
Cancer Death Rates* Among Men, US,1930-2005
100
Rate Per 100,000
Lung & bronchus
80
60
Stomach
Prostate
40
Colon & rectum
20
Pancreas
Leukemia Liver
0
1930
1935
1940
1945
1950
1955
1960
1965
1970
1975
1980
1985
1990
1995
2000
2005
Source: US Mortality Data 1960-2005, US Mortality Volumes 1930-1959,
National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.
Cancer Death Rates* Among Women, US,1930-2005
100
Rate Per 100,000
80
60
Lung & bronchus

40 Uterus
Breast
Colon & rectum

20 Stomach
Ovary
Pancreas
0
1930
1935
1940
1945
1950
1955
1960
1965
1970
1975
1980
1985
1990
1995
2000
2005
Source: US Mortality Data 1960-2005, US Mortality Volumes 1930-1959,
National Center for Health Statistics, Centers for Disease Control and Prevention, 2008.
Cancer Death Rates* by Race and Ethnicity, US, 2001-
2005
400
Men Women
350
313.0
300
250 230.7
186.7 190.0
200
159.2 159.0
138.8 142.0
150
95.6 105.2
100
50
0
White African Asian/Pacific American Hispanic†
American Islander Indian/ Alaskan
Native
*Per 100,000, age-adjusted to the 2000 US standard population.
†
Persons of Hispanic origin may be of any race.
Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control and
Population Sciences, National Cancer Institute, 2008.
Cancer Sites in Men for Which African American Death Rates*
Exceed White Death Rates*, US, 2001-2005
Ratio of African
Site African American White
American/White
All sites 313.0 230.7 1.4

Prostate 59.4 24.6 2.4
Larynx 4.8 2.1 2.3
Stomach 11.5 5.0 2.3
Myeloma 8.3 4.3 1.9
Oral cavity and pharynx 6.7 3.8 1.8
Small intestine 0.7 0.4 1.8
Liver and intrahepatic bile duct 10.3 6.7 1.5
Colon and rectum 31.8 22.1 1.4
Esophagus 9.8 7.8 1.3
Lung and bronchus 93.1 71.3 1.3
Pancreas 15.4 12.1 1.3

Cancer Sites in Women for Which African American Death
Rates* Exceed White Death Rates*, US, 2001-2005
Ratio of African
Site African American White American/White
All sites 186.7 159.2 1.2
Stomach 5.5 2.5 2.2
Myeloma 6.0 2.8 2.1
Uterine cervix 4.7 2.3 2.0
Esophagus 2.8 1.6 1.8
Uterine corpus 7.1 3.9 1.8
Small intestine 0.5 0.3 1.7
Larynx 0.8 0.5 1.6
Colon and rectum 22.4 15.3 1.5
Pancreas 12.4 9.0 1.4
Breast 33.5 24.4 1.4
Gallbladder 1.0 0.8 1.3
Urinary bladder 2.8 2.2 1.3
Liver and intrahepatic bile duct 3.9 2.9 1.3

Source: Surveillance, Epidemiology, and End Results Program, 1975-2005, Division of Cancer Control
and Population Sciences, National Cancer Institute, 2008.
Cancer Death Rates* by Sex and Race, US, 1975-2005
500
Rate Per 100,000
450
African American men
400
350
300
White men
250
African American women
200
150 White women
100
50
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005

2009 Estimated US Cancer Cases*
Men Women
766,130 713,220
Prostate 25% 27% Breast
Lung & bronchus 15% 14% Lung & bronchus
Colon & rectum 10% 10% Colon & rectum
Urinary bladder 7% 6% Uterine corpus
Melanoma of skin 5% 4% Non-Hodgkin
lymphoma
Non-Hodgkin5%
lymphoma 4% Melanoma of skin
Kidney & renal pelvis 5% 4% Thyroid
Leukemia 3% 3% Kidney & renal pelvis
Oral cavity 3% 3% Ovary
Pancreas 3% 3% Pancreas
All Other Sites 19% 22% All Other Sites
*Excludes basal and squamous cell skin cancers and in situ carcinomas except urinary bladder.
Source: American Cancer Society, 2009.
Cancer Incidence Rates* by Sex, US, 1975-2005
700 Rate Per 100,000
600 Men
500 Both Sexes
400 Women
300
200
100
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
*Age-adjusted to the 2000 US standard population and adjusted for delays in reporting.
Source: Surveillance, Epidemiology, and End Results Program, Delay-adjusted Incidence database:
SEER Incidence Delay-adjusted Rates, 9 Registries, 1975-2005, National Cancer Institute, 2008.
Cancer Incidence Rates* Among Men, US, 1975-2005
Rate Per 100,000

250
Prostate
200
150
Lung & bronchus

100
Colon and rectum

50 Urinary bladder
Non-Hodgkin lymphoma
Melanoma of the skin
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
Cancer Incidence Rates* Among Women, US, 1975-2005
Rate Per 100,000

250
200
150 Breast
100
Colon and rectum Lung & bronchus

50
Uterine Corpus
Ovary
Non-Hodgkin lymphoma
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
Cancer Incidence Rates* by Race and Ethnicity, 2001-2005
Rate Per 100,000
800
Men Women
700 651.5
600 551.4
500
423.6 419.4
398.9
400 354.0 336.6 317.8
287.8 296.4
300
200
100
0
White African American Asian/Pacific Islander American Indian/ Hispanic†
Alaska Native

†
Person of Hispanic origin may be of any race.
Cancer Incidence Rates* by Sex and Race, US,1975-2005
Rate Per 100,000
900
800
African American men
700
600 White men
500
White women
400
African American women
300
200
100
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
Lifetime Probability of Developing Cancer, Men, 2003-2005*
Site Risk
All sites† 1 in 2
Prostate 1 in 6
Lung and bronchus 1 in 13
Colon and rectum 1 in 18
Urinary bladder‡ 1 in 27
Melanoma§ 1 in 39
Non-Hodgkin lymphoma 1 in 45
Kidney 1 in 57
Leukemia 1 in 67
Oral Cavity 1 in 72
Stomach 1 in 90
* For those free of cancer at beginning of age interval.
† All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder.
‡ Includes invasive and in situ cancer cases
§ Statistic for white men.
Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 6.3.0 Statistical Research and
Applications Branch, NCI, 2008. http://srab.cancer.gov/devcan
Lifetime Probability of Developing Cancer, Women, US, 2003-2005*
Site Risk
All sites† 1 in 3
Breast 1 in 8
Lung & bronchus 1 in 16
Colon & rectum 1 in 20
Uterine corpus 1 in 40
Non-Hodgkin lymphoma 1 in 53
Urinary bladder‡ 1 in 84
Melanoma§ 1 in 58
Ovary 1 in 72
Pancreas 1 in 75
Uterine cervix 1 in 145
* For those free of cancer at beginning of age interval.

† All Sites exclude basal and squamous cell skin cancers and in situ cancers except urinary bladder.
‡ Includes invasive and in situ cancer cases
§ Statistic for white women.
Source: DevCan: Probability of Developing or Dying of Cancer Software, Version 6.3.0 Statistical Research and
Applications Branch, NCI, 2008. http://srab.cancer.gov/devcan
Cancer Survival*(%) by Race,1996-2004
African Absolute
Site White American Difference
All Sites 68 58 10
Breast (female) 91 78 13
Colon 66 55 11
Esophagus 18 11 7
Leukemia 52 42 10
Non-Hodgkin lymphoma 66 58 8
Oral cavity 62 42 20
Prostate 99 96 3
Rectum 67 59 8
Urinary bladder 82 66 16
Uterine cervix 74 65 9
Uterine corpus 86 61 25
*5-year relative survival rates based on cancer patients diagnosed from 1996 to 2004 and followed through 2005.
Trends in Five-year Relative Survival (%)* Rates, US, 1975-2004
Site 1975-1977 1984-1986 1996-2004

All sites 5054 66

Breast (female) 7579 89
Colon 5259 65
Leukemia 3542 51
Lung and bronchus 1313 16
Melanoma 8287 92
Non-Hodgkin lymphoma 4853 65
Ovary 3740 46
Pancreas 33 5
Prostate 6976 99
Rectum 4957 67
Urinary bladder 7478 81
*5-year relative survival rates based on follow up of patients through 2005.

Cancer Incidence & Death Rates* in Children 0-14 Years, 1975-2005
18 Rate Per 100,000
16 Incidence
14
12
10
4 Mortality
0
1975 1978 1981 1984 1987 1990 1993 1996 1999 2002 2005
*Age-adjusted to the 2000 Standard population.

Cancer Incidence Rates* in Children 0-14 Years by Sex, 2001-2005
Site Male Female Total

All sites 16.1 14.1 15.1
Leukemia 5.4 4.5 5.0
Acute Lymphocytic 4.3 3.6 3.9
Brain/ONS 3.4 3.1 3.2
Soft tissue 1.1 1.0 1.1
Non-Hodgkin lymphoma 1.2 0.6 0.9
Kidney and renal pelvis 0.8 0.8 0.8
Bone and Joint 0.7 0.7 0.7
Hodgkin lymphoma 0.7 0.4 0.5

ONS = Other nervous system
Cancer Death Rates* in Children 0-14 Years by Sex, US, 2001-2005
Site Male Female Total

All sites 2.7 2.3 2.5
Leukemia 0.8 0.7 0.8
Acute Lymphocytic 0.4 0.3 0.4
Brain/ONS 0.8 0.7 0.7
Non-Hodgkin lymphoma 0.1 0.1 0.1
Soft tissue 0.1 0.1 0.1
Bone and Joint 0.1 0.1 0.1
Kidney and Renal pelvis 0.1 0.1 0.1

ONS = Other nervous system
Trends in Cancer Survival by Age Group, Children 0-14 Years,1975-2004
Year of
Age 5 - Year Relative Survival Rates *
Diagnosis
0 - 4 Years
1975 - 1977
1996 - 2004
5 - 9 Years
1975 - 1977
1996 - 2004
10 - 14 Years
1975 - 1977
1996 - 2004
*5-year relative survival rates, based on follow up of patients through 2005.

Tobacco Use in the US, 1900-2005
5000 100
4500 90
Per Capita Cigarette Consumption
Age-Adjusted Lung Cancer Death

4000 80
3500 Per capita cigarette 70

consumption
3000 60
Rates*
2500 50
Male lung cancer
2000 death rate 40
1500 30
1000 20
500 Female lung cancer 10

death rate
0 0
1910
1955
1995
1900
1905
1915
1920
1925
1930
1935
1940
1945
1950
1960
1965
1970
1975
1980
1985
1990
2000
2005
Year
*Age-adjusted to 2000 US standard population.

Source: Death rates: US Mortality Data, 1960-2005, US Mortality Volumes, 1930-1959, National Center for Health
Statistics, Centers for Disease Control and Prevention, 2006. Cigarette consumption: US Department of
Agriculture, 1900-2007.
Trends in Cigarette Smoking Prevalence* (%), by Sex, Adults 18
and Older, US, 1965-2007
60
50
40
Prevalence (%)
30 Men
20
Women
10
0
1974
1979
1985
1995
1998
2002
2005
2006
1965
1983
1990
1992
1994
1997
1999
2000
2001
2003
2004
2007
Year
*Redesign of survey in 1997 may affect trends.

Source: National Health Interview Survey, 1965-2007, National Center for Health Statistics, Centers for Disease
Control and Prevention, 2008.
Current* Cigarette Smoking Prevalence (%) Among High School
Students by Sex and Race/Ethnicity, US, 1991-2007
50
1991 1995 1997 1999 2001 2003
2005 2007
40
40 40
40 39 38
37
3536 34
33 33 32
32 31 32
30
Prevalence (%)
30 2727 2828 28
27
26
25 25
23 23 24 23
22
19 1819 19 19
20 18
17 16
1415 15
13 14
12
1112 11
10 8
0
White, non- White, non- African African Hispanic Hispanic Male
Hispanic Hispanic Male American, non- American, non- Female
Female Hispanic Hispanic Male
Female
*Smoked cigarettes on one or more of the 30 days preceding the survey.

Source: Youth Risk Behavior Surveillance System, 1991, 1995, 1997, 1999, 2001, 2003, 2005, 2007 National Center for
Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2008.
Trends in Consumption of Five or More Recommended Vegetable
and Fruit Servings for Cancer Prevention, Adults 18 and Older,
US, 1994-2007
35
30
24.2 24.4 24.1 24.4 23.6 24.3 24.7
25
Prevalence (%)
20
15
10
0
1994 1996 1998 2000 2003 2005 2007
Year
Note: Data from participating states and the District of Columbia were aggregated to represent the United
States.
Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape
(2000, 2003, 2005, 2007), National Center for Chronic Disease Prevention and Health Promotion, Centers for
Disease Control and Prevention, 1997, 1999, 2000, 2001, 2004, 2006, 2008.
Trends in Prevalence (%) of No Leisure-Time Physical Activity, by
Educational Attainment, Adults 18 and Older, US, 1992-2007
60
Adults with less than a high school education
55
50
45
40
Prevalence (%)
35
30
25 All adults
20
15
10
5
0
1992
1994
1996
1998
2000
2002
2003
2004
2005
2006
2007
Year
Note: Data from participating states and the District of Columbia were aggregated to represent the United
States. Educational attainment is for adults 25 and older.
Source: Behavioral Risk Factor Surveillance System CD-ROM (1984-1995, 1996, 1998) and Public Use Data Tape
(2000, 2002, 2004, 2005, 2006, 2007), National Center for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 1997, 1999, 2000, 2001, 2003, 2005, 2006, 2007, 2008.
Trends in Prevalence (%) of High School Students
Attending PE Class Daily, by Grade, US, 1991-2007
70
60
50
9th
Prevalence (%)
40
10th
30
11th
20
12th
10
0
1991 1993 1995 1997 1999 2001 2003 2005 2007
Year
Source: Source: Youth Risk Behavior Surveillance System, 1991, 1995, 1997, 1999, 2001, 2003, 2005, 2007
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and
Prevention, 2008.
Trends in Obesity* Prevalence (%), Children and Adolescents, by
Age Group, US, 1971-2006
20
18
17
16 16
15
12
Prevalence (%)
11 11
10
10
7
7
6
5 5 5
5 4
0
2 to 5 years 6 to 11 years 12 to 19 years
NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)

NHANES 1999-2002 NHANES 2003-2006
*Body mass index (BMI) at or above the sex-and age-specific 95 th percentile BMI cutoff points from the 2000 sex-
specific BMI-for-age CDC Growth Charts. Note: Previous editions of Cancer Statistics used the term “overweight”
to describe youth in this BMI category.
Source: National Health and Nutrition Examination Survey, 1971-1974, 1976-1980, 1988-1994, 1999-2002, National
Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-2006: Ogden CL, et al.
High Body Mass Index for Age among US Children and Adolescents, 2003-2006. JAMA 2008; 299 (20): 2401-05.
Trends in Obesity* Prevalence (%), By Gender, Adults Aged 20
to 74, US, 1960-2006†
45
40
35 36
33 34 34 35
35 32
31
30 28
26
Prevalence (%)
25 23
21
20 17
16 17
13 15 15
15 12 13
11
10
0
Both sexes Men Women
NHES I (1960-62) NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)

NHANES 1999-2002 NHANES 2003-2004 NHANES 2005-2006
*Obesity is defined as a body mass index of 30 kg/m2 or greater. † Age adjusted to the 2000 US standard population. Source:
National Health Examination Survey 1960-1962, National Health and Nutrition Examination Survey, 1971-1974, 1976-1980,
1988-1994, 1999-2002, National Center for Health Statistics, Centers for Disease Control and Prevention, 2002, 2004. 2003-
2004, 2005-2006: National Health and Nutrition Examination Survey Public Use Data Files, 2003-2004, 2005-2006, National
Center for Health Statistics, Centers for Disease Control and Prevention, 2006, 2007.
Trends in Overweight* Prevalence (%), Adults 18 and
Older, US, 1992-2007
1992 1995
1998 2007
Less than 50% 50 to 55% More than 55% State did not participate in survey
*Body mass index of 25.0 kg/m2or greater. Source: Behavioral Risk Factor Surveillance System, CD-ROM (1984-1995,
1998) and Public Use Data Tape (2004-2007), National Center for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 1997, 2000, 2005, 2007, 2008.
Screening Guidelines for the Early Detection of
Breast Cancer, American Cancer Society
 Yearly mammograms are recommended starting at age 40.
 A clinical breast exam should be part of a periodic health examination,

about every 3 years for women in their 20s and 30s. Asymptomatic women
aged 40 and older should continue to undergo a clinical breast exam,
preferably annually*.
 Beginning in their early 20s, women should be told about the benefits and
limitations of breast-self examination. Women should know how their
breasts normally feel and report any breast changes promptly to their
health care providers.
__________
* Beginning at age 40 years, annual CBE should be performed prior to mammography
Mammogram Prevalence (%), by Educational Attainment and
Health Insurance Status, Women 40 and Older, US, 1991-2006
70
All women 40 and older

60
50
Prevalence (%)
Women with less than a high school education

40
30
Women with no health insurance
20
10
0
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2002 2004 2006
Year
*A mammogram within the past year. Note: Data from participating states and the District of Columbia were
aggregated to represent the United States.
Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and Public Use
Data Tape (2000, 2002, 2004, 2006), National Centers for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, 2007.
Cervical Cancer, American Cancer Society
Screening should begin approximately three years after a women begins

having vaginal intercourse, but no later than 21 years of age.
Screening should be done every year with regular Pap tests or every two
years using liquid-based tests.
At or after age 30, women who have had three normal test results in a row
may get screened every 2-3 years with cervical cytology (either
conventional or liquid-based Pap test) alone, or every 3 years with a
human papillomavirus DNA test plus cervical cytology.
Women 70 and older who have had three or more consecutive Pap tests
in the last ten years may choose to stop cervical cancer screening.
Screening after a total hysterectomy (with removal of the cervix) is not

necessary unless the surgery was done as a treatment for cervical cancer.
Trends in Recent* Pap Test Prevalence (%), by Educational
Attainment and Health Insurance Status, Women 18 and Older,
US, 1992-2006
100
All women 18 and older
80
Women with no health insurance
Women with less than a high school education

Prevalence (%)
60
40
20
0
1992 1993 1994 1995 1996 1997 1998 1999 2000 2002 2004 2006
Year
* A Pap test within the past three years. Note: Data from participating states and the District of Columbia
were aggregated to represent the United States. Educational attainment is for women 25 and older.
Source: Behavior Risk Factor Surveillance System CD-ROM (1984-1995, 1996-1997, 1998, 1999) and
Public Use Data Tape (2000, 2002, 2004, 2006), National Center for Chronic Disease Prevention and Health
Promotion, Center for Disease Control and Prevention, 1997, 1999, 2000, 2000, 2001, 2003, 2005, 2007.
Screening Guidelines for the Early Detection of Colorectal Cancer
and Adenomas, American Cancer Society 2008
Beginning at age 50, men and women should follow one of the
following examination schedules:
 A flexible sigmoidoscopy (FSIG) every five years
 A colonoscopy every ten years
 A double-contrast barium enema every five years
 A Computerized Tomographic (CT) colonography every five years
 A guaiac-based fecal occult blood test (FOBT) or a fecal

immunochemical test (FIT) every year
 A stool DNA test (interval uncertain)
 Tests that detect adenomatous polyps and cancer

 Tests that primarily detect cancer
People who are at moderate or high risk for colorectal cancer should talk with
a doctor about a different testing schedule
Trends in Recent* Fecal Occult Blood Test Prevalence (%), by
Educational Attainment and Health Insurance Status, Adults 50
Years and Older, US, 1997-2006
30
1997 1999 2001 2002
2004 2006
25 24
22
21
20
20 19 18
Prevalence (%)
16 16 16 16
14
15
12 12
9 9 9
10 8 8
0
Total Less than a high school No health insurance
education
*A fecal occult blood test within the past year. Note: Data from participating states and the District of Columbia were
aggregated to represent the United States.
Source: Behavioral Risk Factor Surveillance System CD-ROM (1996-1997, 1999) and Public Use Data Tape (2001,
2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention and Prevention, 1999, 2000, 2002, 2003, 2005, 2007.
Trends in Recent* Flexible Sigmoidoscopy or Colonoscopy
Prevalence (%), by Educational Attainment and Health Insurance
Status, Adults 50 Years and Older, US, 1997-2006
60 56
1999 2001 2002 2004 2006
50
50 45
44 44 43
41
40 37
Pre va le n ce (% )
36 36
30 25
22 21 21 22
20
10
0
education
*A flexible sigmoidoscopy or colonoscopy within the past ten years. Note: Data from participating states and the
District of Columbia were aggregated to represent the United States.
Source: Behavioral Risk Factor Surveillance System CD-ROM (1996-1997, 1999) and Public Use Data Tape (2001,
2002, 2004, 2006), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention and Prevention, 1999, 2000, 2002, 2003, 2005, 2007.
Prostate Cancer, American Cancer Society
 Beginning at age 50, to men who have a life expectancy of

at least 10 years, health care providers should discuss the
potential benefits and limitations of prostate cancer early
detection testing with men and offer the PSA blood test and
the digital rectal examination.*
___________
* Information should be provided to men regarding the benefits and

limitations of testing so that an informed decision concerning testing
can be made with the clinician’s assistance.
Recent* Prostate-Specific Antigen (PSA) Test Prevalence (%),
by Educational Attainment and Health Insurance Status, Men 50
70
2001 2002
58 2004 2006
60 55 54
52
50 46
42
Prevalence (%)
39 40
40
30 28
30 27
25
20
10
0
education
*A prostate-specific antigen (PSA) test within the past year. Note: Data from participating states and the District of
Columbia were aggregated to represent the United States.
Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002, 2004, 2006), National Center
for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003, 2005,
2007.
Recent* Digital Rectal Examination (DRE) Prevalence (%), by
Educational Attainment and Health Insurance Status, Men 50
60 57
53 2001 2002
50 5 0 2004 2006
50
44
42
40 37
Prevalence (%)
35
29
30 26
22 2 3
20
10
0
education
*A digital rectal examination (DRE) within the past year. Note: Data from participating states and the District of
Columbia were aggregated to represent the United States.
Source: Behavioral Risk Factor Surveillance System Public Use Data Tape (2001, 2002, 2004, 2006), National Center
for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2002, 2003, 2005,
2007.
Sunburn* Prevalence (%) in the Past Year, Adults 18 and
Older, US, 2004
50
46.4
45
White non-
40 Hispanic
36.3
Age-Adjusted Prevalence (%)
35
30 Other
26.3
24.0
25 22.5
20 18.4 Hispanic
15
10 Black non-
5.7 5.8
Hispanic
5
0
Male Female
*Reddening of any part of the skin for more than 12 hours. Note: The overall prevalence of sunburn
among adult males is 46.4% and among females is 36.3%.
Source: Behavioral Risk Factor Surveillance System Public Use Data Tape , 2004. National Center for
Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2005.
Ultraviolet Radiation Exposure Behaviors* Prevalence (%),
Adults 18 and Older, US, 2005
Total Male Female
45
40 40
40
37
35 33
30 30
30
26
Prevalence (%)
25 24
19
20
17
15 14
12 13 12
10 11 10 11
10
0
Apply Seek the shade Wear a hat Wear long- Wear long Used indoor
sunscreen sleeved shirt pants tanning
device†
*Proportion of respondents reporting always or often practicing the particular sun protection behavior
on any warm sunny day. †Used an indoor tanning device, including a sunbed, sunlamp, or tanning
booth at least once, in the past 12 months.
Source: National Health Interview Survey Public Use Data File 2005, National Center for Health Statistics,
Centers for Disease Control and Prevention, 2006.
Thank you

American Cancer Society Statistics 2009 Slides

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

American Cancer Society Statistics 2009 Slides

Uploaded by

Copyright:

Available Formats

Cancer Statistics 2009

A Presentation From the

©2009, American Cancer Society, Inc.

ONS=Other nervous system.

2. Cancer 559,888 23.1

3. Cerebrovascular diseases 137,119 5.7

4. Chronic lower respiratory diseases 124,583 5.1

5. Accidents (unintentional injuries) 121,599 5.0

6. Diabetes mellitus 72,449 3.0

7. Alzheimer disease 72,432 3.0

8. Influenza & pneumonia 56,326 2.3

9. Nephritis* 45,344 1.9

10. Septicemia 34,234 1.4

*Includes nephrotic syndrome and nephrosis.

Rate Per 100,000

* Age-adjusted to 2000 US standard population.

300 Rate Per 100,000

Lung & bronchus

Colon & rectum

All sites 313.0 230.7 1.4

*Per 100,000, age-adjusted to the 2000 US standard population.

*Per 100,000, age-adjusted to the 2000 US standard population.

150 White women

*Age-adjusted to the 2000 US standard population.

700 Rate Per 100,000

500 Both Sexes

Rate Per 100,000

Lung & bronchus

Colon and rectum

Rate Per 100,000

Colon and rectum Lung & bronchus

Rate Per 100,000

*Age-adjusted to the 2000 US standard population.

Rate Per 100,000

600 White men

* For those free of cancer at beginning of age interval.

Site 1975-1977 1984-1986 1996-2004

*5-year relative survival rates based on follow up of patients through 2005.

18 Rate Per 100,000

*Age-adjusted to the 2000 Standard population.

Site Male Female Total

*Per 100,000, age-adjusted to the 2000 US standard population.

Site Male Female Total

*Per 100,000, age-adjusted to the 2000 US standard population.

*5-year relative survival rates, based on follow up of patients through 2005.

Age-Adjusted Lung Cancer Death

3500 Per capita cigarette 70

500 Female lung cancer 10

*Age-adjusted to 2000 US standard population.

*Redesign of survey in 1997 may affect trends.

*Smoked cigarettes on one or more of the 30 days preceding the survey.

NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)

NHES I (1960-62) NHANES I (1971-74) NHANES II (1976-80) NHANES III (1988-94)

 Yearly mammograms are recommended starting at age 40.

 A clinical breast exam should be part of a periodic health examination,

All women 40 and older

Women with less than a high school education

Screening should begin approximately three years after a women begins

Screening after a total hysterectomy (with removal of the cervix) is not

Women with less than a high school education

 A flexible sigmoidoscopy (FSIG) every five years

 A colonoscopy every ten years

 A double-contrast barium enema every five years

 A Computerized Tomographic (CT) colonography every five years